Home › Breast cancer gene judgment opens up complex questions
 

Keywords :   


Breast cancer gene judgment opens up complex questions

2015-10-09 20:07:22| Biotech - Topix.net

This week saw a major victory for cancer patients and advocates who fought to regain control of their genes. But in the fast-changing world of medical research, who will own the rights to future discoveries? The High Court ruling against patenting BRCA1 means Myriad Genetics no longer own the mutation test and scientists outside the company will be able to extend research into the breast cancer gene, explains health editor Amy Corderoy.

Tags: questions complex cancer gene

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05Eastern North Pacific Tropical Weather Outlook
20.05Atlantic Tropical Weather Outlook
20.05Water investors have withdrawn billions, says research
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
19.05IT Cosmetics and Kenvue Launch New Products
19.05Virgin Trains targets West Coast in return to rail
19.05Cashing In On The Stache
More »